aTyr Pharma Inc (LIFE)
0.4299
+0.01 +1.66%
NASDAQ
Dec 18, 16:58
Delayed 2m
USD
View All Key Stats
LIFE Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.32 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -39.67M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 12.91M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.3311 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -6.496M |
| Return on Equity (TTM) | Upgrade |
View All LIFE News
LIFE News
-
WireHeadlineTime (ET)
-
SA Breaking News12/04 09:27
-
Globe Newswire12/04 08:00
-
Yahoo11/29 08:06
-
Globe Newswire11/28 20:16
-
Yahoo11/28 07:04
-
Globe Newswire11/21 08:50
-
SA Breaking News11/16 12:55
-
MT Newswires11/13 17:54
-
Yahoo11/13 16:21
-
SA Breaking News11/13 16:15
View All Events
LIFE Events
| Date | Type | Description |
|---|---|---|
| 03/19/2019 17:00 EDT | Misc | aTyr Pharma Inc Fourth Quarter Earnings Conference Call in 2018 |
| 08/10/2018 | Earnings | aTyr Pharma Inc Second Quarter Earnings Results in 2018 |
| 05/15/2018 | Misc | aTyr Pharma Inc Annual General Meeting in 2017 |
| 05/14/2018 08:00 EDT | Misc | aTyr Pharma Inc First Quarter Earnings Conference Call in 2018 |
| 05/14/2018 | Earnings | aTyr Pharma Inc First Quarter Earnings in 2018 Release |
| 03/19/2018 17:00 EDT | Misc | aTyr Pharma Inc Fourth Quarter Earnings Conference Call in 2017 |
| 03/19/2018 | Earnings | aTyr Pharma Inc Fourth Quarter Earnings Results in 2017 |
LIFE Fundamentals
Income Statement View Statement
LIFE Ratings
Advertisement
LIFE One Page Reports
- One Page Report Download
LIFE Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.4299 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.atyrpharma.com
- Investor Relations URL: http://atyrpharma.investorroom.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 10, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology.
LIFE Excel Add-In Codes
- Name: =YCI("LIFE","name")
- Description: =YCI("LIFE","description")
- Sector: =YCI("LIFE","sector")
- Industry: =YCI("LIFE","industry")
- Est. Current Fiscal Year End: =YCI("LIFE","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other LIFE Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- LIFE Tweets Stocktwits
Advertisement
